Latest Regulatory Approval News

Li-FT Power has signed a definitive agreement to acquire Azimut Exploration's 50% interest in the Galinée lithium property, a crucial step enabling its planned takeover of Winsome Resources. This deal strengthens Li-FT's position in Quebec's lithium sector alongside Winsome's flagship Adina project.

DigiCo Infrastructure REIT has received key regulatory approval to expand its SYD1 data centre in Ultimo, NSW, enabling a significant capacity upgrade amid strong tenant demand.

High Peak Royalties finalises the sale of its geothermal subsidiary Torrens Energy to Northstar Energy, gaining significant equity and royalty interests while advancing South Australia's clean energy ambitions.

Clarity Pharmaceuticals’ novel diagnostic agent Cu-SAR-bisPSMA has been selected for oral presentation at the prestigious European Association of Urology Congress 2026, following promising Phase II trial results demonstrating superior detection of prostate cancer recurrence.

Forrestania Resources has acquired key tenements at Mt Dimer from Beacon Minerals, significantly expanding its gold exploration footprint in Western Australia’s Southern Cross Domain. The move aligns with the company’s strategy to consolidate and explore highly prospective gold belts.

Infini Resources has strategically expanded its Portland Creek Uranium Project in Newfoundland by acquiring adjacent mineral licences, increasing its landholding by 30% and reinforcing its position in a promising uranium district.

Western Gold Resources has approved the Decision to Mine for its Gold Duke Project, marking a key shift from exploration to production with first gold targeted in early 2026.

European Metals Holdings has released a Definitive Feasibility Study confirming the Cinovec Lithium Project as a long-life, battery-grade lithium carbonate producer strategically positioned to supply Europe's electric vehicle and energy storage sectors.

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.

Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.

Invion Limited’s partner Hanlim Pharm, backed by South Korea’s government grant, has secured up to A$2 million in non-dilutive funding to advance preclinical studies of HL270 for oesophageal cancer, paving the way for human trials in Australia.

Fenix Resources’ latest Scoping Study outlines a robust plan to ramp up Weld Range iron ore production to 10 million tonnes per annum by 2031, extending mine life to 2042 with significantly reduced costs and strong financial returns.